CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 14 enrolled
Drug / intervention
EUS + SHAM +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04232670
NCT04232670N/ACompleted

Pancreatic Endotherapy for Refractory Chronic Pancreatitis

Oregon Health and Science University·interventional·Posted Jan 18, 2020·Updated Sep 24, 2025

In Brief

A clinical study evaluating EUS + SHAM and EUS + Pancreatic Endotherapy for Pancreatic Duct Stone and 2 related conditions. Completed, enrolled 14 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate whether endoscopic ultrasound (EUS) only versus EUS + endoscopic retrograde cholangiopancreatography (ERCP) with pancreatic endotherapy reduces pain in the treatment of chronic pancreatitis with pancreatic duct obstruction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJan 18, 2020
Enrollment StartOct 9, 2020
Primary CompletionJun 30, 2024
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 6.5 years ago

Interventions

EUS + SHAMprocedure

Endoscopic Ultrasound

EUS + Pancreatic Endotherapyprocedure

Pancreatic endotherapy may include any or all of the following maneuvers: pancreatic endoscopic sphincterotomy, stricture dilation using a bougie or hydrostatic balloon catheter, pancreatic stone extraction with or without mechanical or electrohydraulic lithotripsy, extracorporeal shock wave lithotripsy, and stent placement.